Tumor-Mediated Suppression of Dendritic Cell Vaccines

doi 10.21236/ada428247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

50PExtracellular Vesicle-Internalizing Receptors (EVIRs) for Dendritic Cell-Based Tumor Vaccines

Annals of Oncology
MedicineOncologyHematology
2017English

Allogeneic Tumor Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Clinical Applications of Dendritic Cell Cancer Vaccines

Oncologist
Cancer ResearchMedicineOncology
1999English

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Exosomes and Tumor-Mediated Immune Suppression

Journal of Clinical Investigation
Medicine
2016English

Vps4A-Mediated Tumor Suppression Upon Exosome Modulation?

Annals of Translational Medicine
Medicine
2016English

Virotherapy-Recruited PMN-MDSC Infiltration of Mesothelioma Blocks Antitumor CTL by IL-10-mediated Dendritic Cell Suppression

OncoImmunology
OncologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy